Sunshine Biopharma Inc. (SBFM)
NASDAQ · Healthcare
Sunshine Biopharma Inc. Operating Income 2017–2025
Sunshine Biopharma Inc. annual/quarterly operating income history and growth rate from 2017 to 2026. Operating income (EBIT) is profit from core business operations, excluding interest and income taxes. It reflects the efficiency of a company's core operations.
- Sunshine Biopharma Inc. operating income for the quarter ending March 31, 2026 was -1.4 M, a 7.71% increase year-over-year.
- Sunshine Biopharma Inc. operating income for the twelve months ending March 31, 2026 was -5.8 M, a 29.48% increase year-over-year.
- Sunshine Biopharma Inc. annual operating income for 2025 was -6.2 M, a 7.14% increase from 2024.
- Sunshine Biopharma Inc. annual operating income for 2024 was -5.8 M, a 21.46% increase from 2023.
- Sunshine Biopharma Inc. annual operating income for 2023 was -4.8 M, a 82.28% decrease from 2022.
- Sunshine Biopharma Inc. annual operating income for 2022 was -27.0 M.
Operating Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Sunshine Biopharma Inc. Operating Income — FAQ
Sunshine Biopharma Inc. (SBFM) operating income over the last 9 years — annual and quarterly figures with year-over-year growth and charts.
What is Sunshine Biopharma Inc.'s operating income?
Sunshine Biopharma Inc. (SBFM) reported operating income of -$6M for fiscal 2025.
Where can I see SBFM's operating income history?
The chart and table above show Sunshine Biopharma Inc.'s operating income by year and by quarter, including the growth rate.